| Identification | Back Directory | [Name]
H-PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL-OH | [CAS]
160295-81-8 | [Synonyms]
FLWGPRALV
MAGE-3 (271-279)
H2N-FLWGPRALV-OH
MAGE-3 HUMAN (271-279)
MAGE-3 ANTIGEN (271-279) (HUMAN)
PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL
H-PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL-OH
PHE-LEU-TRP-GLY-PRO-ARG-ALA-LEU-VAL: FLWGPRALV
MELANOMA-ASSOCIATED ANTIGEN 3 (271-279) (HUMAN)
MAGE-3 Antigen (271-279) (huMan)
MelanoMa-Associated Antigen 3 (271-279) (huMan)
L-Phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-L-arginyl-L-alanyl-L-leucyl-L-valine
L-Valine, L-phenylalanyl-L-leucyl-L-tryptophylglycyl-L-prolyl-L-arginyl-L-alanyl-L-leucyl- | [Molecular Formula]
C53H79N13O10 | [MDL Number]
MFCD00943339 | [MOL File]
160295-81-8.mol | [Molecular Weight]
1058.28 |
| Hazard Information | Back Directory | [Uses]
MAGE-3 (271-279) is a 271-279 residue peptide derived from melanoma antigens encoded by MAGE-3. MAGE-3 is a cytolytic T lymphocyte (CTL)-defined MAGE-3 protein associated with the human leukocyte antigen (HLA)-A2 molecule. MAGE-3 is overexpressed in different human tumor types, including malignant melanoma, but not by normal tissues except for testis and placenta[1]. | [References]
[1] J Herman, et al. A peptide encoded by the human MAGE3 gene and presented by HLA-B44 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE3. Immunogenetics. 1996;43(6):377-83. DOI:10.1007/BF02199806 |
|
|